Back
TransCode Therapeutics, Inc. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
22
RNAZ
TransCode Therapeutics, Inc.
Last Price:
$8.59
Seasonality Move:
-30.19%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAZ is experiencing slight buying pressure.
TransCode Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9 | Sell |
| 20-day SMA: | 9.02 | Sell |
| 50-day SMA: | 11.02 | Sell |
| 200-day SMA: | 16.87 | Sell |
| 8-day EMA: | 8.89 | Sell |
| 20-day EMA: | 9.36 | Sell |
| 50-day EMA: | 10.33 | Sell |
| 200-day EMA: | 1250.59 | Sell |
TransCode Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.61 | Sell |
| Relative Strength Index (14 RSI): | 37.76 | Sell |
| Chaikin Money Flow: | 410 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.6 - 9.96) | Sell |
| Bollinger Bands (100): | (9.26 - 12.54) | Sell |
TransCode Therapeutics, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for TransCode Therapeutics, Inc. Stock
Is TransCode Therapeutics, Inc. Stock a Buy?
-
TransCode Therapeutics, Inc. share price is 8.64 while RNAZ 8-day simple moving average is 9.00, which is a Sell signal.
-
The stock price of RNAZ is 8.64 while TransCode Therapeutics, Inc. 20-day SMA is 9.02, which makes it a Sell.
-
TransCode Therapeutics, Inc. 50-day simple moving average is 11.02 while RNAZ share price is 8.64, making it a Sell technically.
-
RNAZ stock price is 8.64 and TransCode Therapeutics, Inc. 200-day simple moving average is 16.87, creating a Sell signal.
RNAZ Technical Analysis vs Fundamental Analysis
Sell
22
TransCode Therapeutics, Inc. (RNAZ)
is a Sell
Is TransCode Therapeutics, Inc. a Buy or a Sell?
-
TransCode Therapeutics, Inc. stock is rated a SellThe current TransCode Therapeutics, Inc. [RNAZ] share price is $8.64. The Score for RNAZ is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
TransCode Therapeutics, Inc. Stock Info
Market Cap:
7.2M
Price in USD:
8.64
Share Volume:
3.3K
TransCode Therapeutics, Inc. 52-Week Range
52-Week High:
468.44
52-Week Low:
6.15
Sell
22
TransCode Therapeutics, Inc. (RNAZ)
is a Sell
TransCode Therapeutics, Inc. Share Price Forecast
-
What is the TransCode Therapeutics, Inc. stock price today?The TransCode Therapeutics, Inc. stock price is 8.64 USD today.
-
Will RNAZ stock go up or go down?TransCode Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is TransCode Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, TransCode Therapeutics, Inc. is overvalued.
Is TransCode Therapeutics, Inc. Stock a Buy?
-
TransCode Therapeutics, Inc. share price is 8.64 while RNAZ 8-day exponential moving average is 8.89, which is a Sell signal.
-
The stock price of RNAZ is 8.64 while TransCode Therapeutics, Inc. 20-day EMA is 9.36, which makes it a Sell.
-
TransCode Therapeutics, Inc. 50-day exponential moving average is 10.33 while RNAZ share price is 8.64, making it a Sell technically.
-
RNAZ stock price is 8.64 and TransCode Therapeutics, Inc. 200-day simple moving average is 1,250.59, creating a Sell signal.
Fundamental Analysis of TransCode Therapeutics, Inc.
Is TransCode Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $131.65 per share, and an increase next year of $1.31 per share.
Technical Analysis of TransCode Therapeutics, Inc.
Should I short TransCode Therapeutics, Inc. stock?
-
RNAZ Moving Average Covergence Divergence (MACD) indicator is -0.61, suggesting TransCode Therapeutics, Inc. is a Sell
-
TransCode Therapeutics, Inc. Relative Strength Index (RSI) is 37.76, which suggest TransCode Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for TransCode Therapeutics, Inc. is (8.6 - 9.96), which suggest TransCode Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for TransCode Therapeutics, Inc. is (9.26 - 12.54), which suggest TransCode Therapeutics, Inc. is a Sell
* TransCode Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.